標(biāo)題: Titlebook: Drug Adherence in Hypertension and Cardiovascular Protection; Michel Burnier Book 2018 Springer International Publishing AG, part of Sprin [打印本頁] 作者: Dangle 時(shí)間: 2025-3-21 19:25
書目名稱Drug Adherence in Hypertension and Cardiovascular Protection影響因子(影響力)
書目名稱Drug Adherence in Hypertension and Cardiovascular Protection影響因子(影響力)學(xué)科排名
書目名稱Drug Adherence in Hypertension and Cardiovascular Protection網(wǎng)絡(luò)公開度
書目名稱Drug Adherence in Hypertension and Cardiovascular Protection網(wǎng)絡(luò)公開度學(xué)科排名
書目名稱Drug Adherence in Hypertension and Cardiovascular Protection被引頻次
書目名稱Drug Adherence in Hypertension and Cardiovascular Protection被引頻次學(xué)科排名
書目名稱Drug Adherence in Hypertension and Cardiovascular Protection年度引用
書目名稱Drug Adherence in Hypertension and Cardiovascular Protection年度引用學(xué)科排名
書目名稱Drug Adherence in Hypertension and Cardiovascular Protection讀者反饋
書目名稱Drug Adherence in Hypertension and Cardiovascular Protection讀者反饋學(xué)科排名
作者: Astigmatism 時(shí)間: 2025-3-21 21:53
https://doi.org/10.1007/978-3-662-24745-7ons and a maximum of 2?hours of post-DOT-HTN observation. Three reports had longer observation time, two of them with medication administration intervals, and blood pressure measurement intervals. Two were case reports, describing severe post-DOT-HTN adverse reactions, contributing with important sa作者: irritation 時(shí)間: 2025-3-22 01:12
https://doi.org/10.1007/978-3-662-24745-7 cannot be assessed this way. These uncertainties reduce the value of biochemical monitoring. Biochemical monitoring of adherence should be preceded by informed consent unless it is performed for research purposes at the group level and with necessary ethical approval. The risk/benefit ratio of bioc作者: Maximize 時(shí)間: 2025-3-22 06:30
https://doi.org/10.1007/978-3-662-24745-7hers in lower tolerability. We discuss how this heterogeneity of treatment effect may lead to differential impacts of antihypertensive drugs on medication adherence among individual patients. We conclude by suggesting approaches to preventing adverse effects of antihypertensive drugs on medication a作者: 猛然一拉 時(shí)間: 2025-3-22 10:46 作者: AGGER 時(shí)間: 2025-3-22 15:32
https://doi.org/10.1007/978-3-662-24745-7e and avoid unnecessary treatment intensification. Given the expanding population with uncontrolled and resistant hypertension and emerging cost–benefits of adherence, addressing non-adherence to prescribed antihypertensive therapy is a top priority.作者: AGGER 時(shí)間: 2025-3-22 18:36
Adherence to Antihypertensive and Cardiovascular Preventive Treatment: The Contribution of the?Lombadherence to statin treatment; and (4) there was a significant positive relationship between reduced adherence to treatment and increased risk of hospitalization for coronary disease, cerebrovascular disease, and heart failure. This was the case in younger and older patients, including those >85 year作者: folliculitis 時(shí)間: 2025-3-22 21:18
Directly Observed Therapy in Hypertension (DOT-HTN)ons and a maximum of 2?hours of post-DOT-HTN observation. Three reports had longer observation time, two of them with medication administration intervals, and blood pressure measurement intervals. Two were case reports, describing severe post-DOT-HTN adverse reactions, contributing with important sa作者: LURE 時(shí)間: 2025-3-23 04:03 作者: 法官 時(shí)間: 2025-3-23 05:33 作者: 是比賽 時(shí)間: 2025-3-23 10:45
Medication Persistence in Hypertension in General Practicely, medication persistence increases with advancing age, is higher in women than in men, and varies with comorbidities. Also, higher income, native-born citizens, and a high number of visits to the physician are all related to increased persistence. Studies on medication persistence are important, a作者: averse 時(shí)間: 2025-3-23 15:55 作者: badinage 時(shí)間: 2025-3-23 18:21
Drug Adherence in Hypertension and Cardiovascular Protection作者: 抑制 時(shí)間: 2025-3-24 01:48 作者: phlegm 時(shí)間: 2025-3-24 02:52
2366-4606 as resistant hypertension, dyslipidemia and hypertension associated with cardiovascular risk. As experts confronted with drug adherence in their daily practice, the authors analyse the real effectiveness of sev978-3-030-09528-4978-3-319-76593-8Series ISSN 2366-4606 Series E-ISSN 2366-4614 作者: Recess 時(shí)間: 2025-3-24 10:24
Taxonomy of Medication Adherence: Recent Developments,ne. It is a major concern for all health care providers including health authorities. Indeed, a poor adherence to medication is an enormous waste not only in terms of unused medications but also in terms of lack of clinical benefits, poor quality of life for patients, increased use of medical resour作者: 白楊 時(shí)間: 2025-3-24 13:36 作者: 不連貫 時(shí)間: 2025-3-24 15:12
Electronic Monitoring of Medication Adherence: From Dose-Counting to Dose-Clockingicacy and side effects, and doses set needlessly high. The use of electronic monitors provides a continuous, compiled in real time, record of patient dosing times, dates, and patterns. Knowing the . of patient dosing activity allows one to accurately gauge drug efficacy and build reliable prognostic作者: Keshan-disease 時(shí)間: 2025-3-24 19:23
Measurements of Antihypertensive Medications in Blood and Urineemical analysis by high performance liquid chromatography-tandem mass spectrometry (LC-MS/MS) provides a direct, objective and robust confirmation of the presence or absence of prescribed antihypertensive medications in bodily fluids. This chapter covers the laboratory principles and the clinical as作者: Presbycusis 時(shí)間: 2025-3-25 02:42
Adherence to Antihypertensive and Cardiovascular Preventive Treatment: The Contribution of the?Lomba databases, which include all residents of this region of northern Italy (>10 million). In Italy free or about free health care is provided for all citizens, including antihypertensive, lipid lowering, and antidiabetic drugs upon prescription. This allows to assess adherence from prescription renewa作者: Minikin 時(shí)間: 2025-3-25 04:46 作者: 一夫一妻制 時(shí)間: 2025-3-25 10:13
Digital Medicines to Measure Drug Ingestion Adherencen their performance via a mobile device application and allows providers to review patients’ medication adherence and activity. Digital medicines have been shown through clinical studies and real-world use to provide benefits for patients with diabetes and hypertension, as well as other diseases.作者: aristocracy 時(shí)間: 2025-3-25 11:48 作者: AIL 時(shí)間: 2025-3-25 17:38
Determinants and Barriers to Adherence in Hypertensionl hypertension, many obstacles may occur which impair his/her ability to stay on therapy. In this chapter, we will review the determinants and barriers to adherence in hypertension utilizing the WHO Multidimensional Adherence Model classification, showing in which phase of the adherence process they作者: Cursory 時(shí)間: 2025-3-25 21:09 作者: 怕失去錢 時(shí)間: 2025-3-26 01:09 作者: Militia 時(shí)間: 2025-3-26 04:34 作者: Cytology 時(shí)間: 2025-3-26 11:56
Medication Persistence in Hypertension in General Practiceo discontinuation of therapy and may also consider the intensity of medication-taking behaviour within this interval. Registers on pharmacy claims data have been proposed as the golden standard in medication persistence research. Generally, persistence rate decreases with time. Medication persistenc作者: 揮舞 時(shí)間: 2025-3-26 15:30 作者: sleep-spindles 時(shí)間: 2025-3-26 19:48
https://doi.org/10.1007/978-3-319-76593-8drug adherence monitoring; resistant hypertension; clinical trials; healthcare network; cost-effectivene作者: Bernstein-test 時(shí)間: 2025-3-27 00:16
978-3-030-09528-4Springer International Publishing AG, part of Springer Nature 2018作者: obtuse 時(shí)間: 2025-3-27 01:21
Digital Medicines to Measure Drug Ingestion Adherencen their performance via a mobile device application and allows providers to review patients’ medication adherence and activity. Digital medicines have been shown through clinical studies and real-world use to provide benefits for patients with diabetes and hypertension, as well as other diseases.作者: 清晰 時(shí)間: 2025-3-27 05:59 作者: semble 時(shí)間: 2025-3-27 13:20 作者: Flatter 時(shí)間: 2025-3-27 16:49
Vorlesungen über Topographische Anatomieicacy and side effects, and doses set needlessly high. The use of electronic monitors provides a continuous, compiled in real time, record of patient dosing times, dates, and patterns. Knowing the . of patient dosing activity allows one to accurately gauge drug efficacy and build reliable prognostic作者: Bereavement 時(shí)間: 2025-3-27 18:53 作者: rectum 時(shí)間: 2025-3-27 22:55 作者: jovial 時(shí)間: 2025-3-28 03:49
https://doi.org/10.1007/978-3-662-24745-7n hypertension research and reported in the literature since 2011 with emphasis on treatment resistant hypertensive (TRH) patients. The aim of this review is to identify how the DOT-HTN procedure has been applied in ongoing and published research. Researchers from four nations were identified being 作者: 法律的瑕疵 時(shí)間: 2025-3-28 07:42
https://doi.org/10.1007/978-3-662-24745-7n their performance via a mobile device application and allows providers to review patients’ medication adherence and activity. Digital medicines have been shown through clinical studies and real-world use to provide benefits for patients with diabetes and hypertension, as well as other diseases.作者: 四指套 時(shí)間: 2025-3-28 13:51
https://doi.org/10.1007/978-3-662-24745-7ately. Reluctance to take preventive medication over long periods of time must be handled with respect for the individuals’ integrity and autonomy. Information procedures are important ethical issues when evaluating adherence. Pharmacy claims of prescriptions reflect persistence and may provide info作者: 闖入 時(shí)間: 2025-3-28 16:35
https://doi.org/10.1007/978-3-662-24745-7l hypertension, many obstacles may occur which impair his/her ability to stay on therapy. In this chapter, we will review the determinants and barriers to adherence in hypertension utilizing the WHO Multidimensional Adherence Model classification, showing in which phase of the adherence process they作者: 凹處 時(shí)間: 2025-3-28 20:35
https://doi.org/10.1007/978-3-662-24745-7 poor with less than 50% of people adhering to treatment as prescribed. Many people do not even begin taking the medication, and even when treatment is initiated, early discontinuation is common. There have been many adherence interventions developed to promote adherence; however, the effectiveness 作者: 我悲傷 時(shí)間: 2025-3-29 01:04 作者: 概觀 時(shí)間: 2025-3-29 04:26 作者: ARC 時(shí)間: 2025-3-29 08:53
https://doi.org/10.1007/978-3-662-24745-7o discontinuation of therapy and may also consider the intensity of medication-taking behaviour within this interval. Registers on pharmacy claims data have been proposed as the golden standard in medication persistence research. Generally, persistence rate decreases with time. Medication persistenc作者: judiciousness 時(shí)間: 2025-3-29 12:29 作者: 生意行為 時(shí)間: 2025-3-29 16:08 作者: 評(píng)論者 時(shí)間: 2025-3-29 20:43 作者: Highbrow 時(shí)間: 2025-3-30 00:32
Drug Adherence in Hypertension and Cardiovascular Protection978-3-319-76593-8Series ISSN 2366-4606 Series E-ISSN 2366-4614 作者: Fillet,Filet 時(shí)間: 2025-3-30 07:12 作者: Facilities 時(shí)間: 2025-3-30 09:09 作者: Accord 時(shí)間: 2025-3-30 16:07
Determinants and Barriers to Adherence in Hypertensions to adherence in hypertension utilizing the WHO Multidimensional Adherence Model classification, showing in which phase of the adherence process they intervene. We will review how these barriers may complicate the therapeutic history of a hypertensive patient based on a clinical case.作者: NUL 時(shí)間: 2025-3-30 19:16
Vorlesungen über Topographische Anatomies and claims. Objective dosing history data supports faster, smarter clinical drug development and avoids wasting time and money in medical practice. Failure to monitor individual dosing patterns means discounting the impact of poor adherence—the factor that is emerging as the single greatest cause of failed drug therapy.作者: 暖昧關(guān)系 時(shí)間: 2025-3-30 21:59 作者: 顯而易見 時(shí)間: 2025-3-31 04:33
2366-4606 in clinical trials..Highlights the role of a multidisciplina.This book provides a critical and comprehensive review of the methodologies available for measuring drug adherence in clinical practice, including those relying on emerging technologies. The authors discuss the risk factors of non-adherenc
